Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine / Andras Heczey, MD |
Bio-Therapeutic Impact Award |
2017 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |
High-throughput CAR NKT Library Screen for Improving Neuroblastoma Immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
Young Investigator Grants |
2020 |
Texas |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Function and Dependency of NFkB Activity in ZFTA-RELA Fusion Ependymoma |
Baylor College of Medicine / Austin Stuckert, MD |
Young Investigator Grants |
2021 |
Texas |
GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma |
Baylor College of Medicine / Kyle Eagen, PhD |
R Accelerated Award Grants |
2022 |
Texas |
Inhibition of Cathepsins to Treat Neuroblastoma |
Alfred I duPont Hospital for Children / Robert Mason |
Innovation Grants |
2008 |
Delaware |